nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Androgen receptor as a therapeutic target
|
Gao, Wenqing |
|
2010 |
154-155 |
13 |
p. 1277-1284 8 p. |
artikel |
2 |
Cell responses to the mechanochemical microenvironment—Implications for regenerative medicine and drug delivery
|
Rehfeldt, Florian |
|
2007 |
154-155 |
13 |
p. 1329-1339 11 p. |
artikel |
3 |
Cellular and multicellular form and function
|
Liu, Wendy F. |
|
2007 |
154-155 |
13 |
p. 1319-1328 10 p. |
artikel |
4 |
Clinical experience with anthracycline antibiotics–HPMA copolymer–human immunoglobulin conjugates
|
Rihova, Blanka |
|
2009 |
154-155 |
13 |
p. 1149-1158 10 p. |
artikel |
5 |
Combination therapy: Opportunities and challenges for polymer–drug conjugates as anticancer nanomedicines
|
Greco, Francesca |
|
2009 |
154-155 |
13 |
p. 1203-1213 11 p. |
artikel |
6 |
Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin
|
Davis, Mark E. |
|
2009 |
154-155 |
13 |
p. 1189-1192 4 p. |
artikel |
7 |
Design and development of polymer conjugates as anti-angiogenic agents
|
Segal, Ehud |
|
2009 |
154-155 |
13 |
p. 1159-1176 18 p. |
artikel |
8 |
Development of HPMA copolymer–anticancer conjugates: Clinical experience and lessons learnt
|
Duncan, Ruth |
|
2009 |
154-155 |
13 |
p. 1131-1148 18 p. |
artikel |
9 |
Development of novel therapeutic strategy by regulating the nuclear hormone receptors
|
Xie, Wen |
|
2010 |
154-155 |
13 |
p. 1217- 1 p. |
artikel |
10 |
Editorial Board
|
|
|
2009 |
154-155 |
13 |
p. ii- 1 p. |
artikel |
11 |
Editorial Board
|
|
|
2010 |
154-155 |
13 |
p. ii- 1 p. |
artikel |
12 |
Editorial Board
|
|
|
2005 |
154-155 |
13 |
p. ii- 1 p. |
artikel |
13 |
Editorial Board
|
|
|
2007 |
154-155 |
13 |
p. ii- 1 p. |
artikel |
14 |
Editorial Board
|
|
|
2011 |
154-155 |
13 |
p. ii- 1 p. |
artikel |
15 |
Editorial Board
|
|
|
2012 |
154-155 |
13 |
p. ii- 1 p. |
artikel |
16 |
Embryonic stem cell science and the therapeutic interface
|
Pouton, Colin W. |
|
2005 |
154-155 |
13 |
p. 1891-1893 3 p. |
artikel |
17 |
Embryonic stem cells: Meeting the needs for cell therapy
|
Mitjavila-Garcia, Maria Teresa |
|
2005 |
154-155 |
13 |
p. 1935-1943 9 p. |
artikel |
18 |
Embryonic stem cells: Understanding their history, cell biology and signalling
|
Friel, Ruairi |
|
2005 |
154-155 |
13 |
p. 1894-1903 10 p. |
artikel |
19 |
Epigenetics advancing personalized nanomedicine in cancer therapy
|
Liu, Shujun |
|
2012 |
154-155 |
13 |
p. 1532-1543 12 p. |
artikel |
20 |
ES cell technology: An introduction to genetic manipulation, differentiation and therapeutic cloning
|
Hook, Lilian |
|
2005 |
154-155 |
13 |
p. 1904-1917 14 p. |
artikel |
21 |
Fibroblast mechanics in 3D collagen matrices
|
Rhee, Sangmyung |
|
2007 |
154-155 |
13 |
p. 1299-1305 7 p. |
artikel |
22 |
Formulating Biomolecules: Mechanistics Insights in Molecular Interactions
|
Chan, Kim |
|
2011 |
154-155 |
13 |
p. 1051-1052 2 p. |
artikel |
23 |
Functional crosstalk of CAR–LXR and ROR–LXR in drug metabolism and lipid metabolism
|
Xiao, Lei |
|
2010 |
154-155 |
13 |
p. 1316-1321 6 p. |
artikel |
24 |
Functional polymers as therapeutic agents: Concept to market place
|
Dhal, Pradeep K. |
|
2009 |
154-155 |
13 |
p. 1121-1130 10 p. |
artikel |
25 |
Genomic perspectives in inter-individual adverse responses following nanomedicine administration: The way forward
|
Moghimi, S. Moein |
|
2012 |
154-155 |
13 |
p. 1385-1393 9 p. |
artikel |
26 |
Growth factor binding to the pericellular matrix and its importance in tissue engineering
|
Macri, Lauren |
|
2007 |
154-155 |
13 |
p. 1366-1381 16 p. |
artikel |
27 |
Hyaluronan-dependent pericellular matrix
|
Evanko, Stephen P. |
|
2007 |
154-155 |
13 |
p. 1351-1365 15 p. |
artikel |
28 |
Immunomicelles for advancing personalized therapy
|
Sawant, Rupa R. |
|
2012 |
154-155 |
13 |
p. 1436-1446 11 p. |
artikel |
29 |
Interactions of formulation excipients with proteins in solution and in the dried state
|
Ohtake, Satoshi |
|
2011 |
154-155 |
13 |
p. 1053-1073 21 p. |
artikel |
30 |
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine
|
Zhang, Xue-Qing |
|
2012 |
154-155 |
13 |
p. 1363-1384 22 p. |
artikel |
31 |
Legal and ethical status of stem cells as medicinal products
|
Tsang, Lincoln |
|
2005 |
154-155 |
13 |
p. 1970-1980 11 p. |
artikel |
32 |
Liposome imaging agents in personalized medicine
|
Petersen, Anncatrine L. |
|
2012 |
154-155 |
13 |
p. 1417-1435 19 p. |
artikel |
33 |
Microgels and microcapsules in peptide and protein drug delivery
|
Bysell, Helena |
|
2011 |
154-155 |
13 |
p. 1172-1185 14 p. |
artikel |
34 |
Micromechanical control of cell and tissue development: Implications for tissue engineering
|
Ghosh, Kaustabh |
|
2007 |
154-155 |
13 |
p. 1306-1318 13 p. |
artikel |
35 |
Molecular fabrications of smart nanobiomaterials and applications in personalized medicine
|
Koutsopoulos, Sotirios |
|
2012 |
154-155 |
13 |
p. 1459-1476 18 p. |
artikel |
36 |
Molecular level insight into intra-solvent interaction effects on protein stability and aggregation
|
Shukla, Diwakar |
|
2011 |
154-155 |
13 |
p. 1074-1085 12 p. |
artikel |
37 |
Molecular origins of surfactant-mediated stabilization of protein drugs
|
Lee, Hyo Jin |
|
2011 |
154-155 |
13 |
p. 1160-1171 12 p. |
artikel |
38 |
Multiple aspects of the interaction of biomacromolecules with inorganic surfaces
|
Fenoglio, Ivana |
|
2011 |
154-155 |
13 |
p. 1186-1209 24 p. |
artikel |
39 |
Nanoproteomics enabling personalized nanomedicine
|
Nicolini, Claudio |
|
2012 |
154-155 |
13 |
p. 1522-1531 10 p. |
artikel |
40 |
Nanotheranostics for personalized medicine
|
Mura, Simona |
|
2012 |
154-155 |
13 |
p. 1394-1416 23 p. |
artikel |
41 |
Natural and artificial cellular microenvironments for soft tissue repair
|
Clark, Richard A.F. |
|
2007 |
154-155 |
13 |
p. 1291-1292 2 p. |
artikel |
42 |
Nonviral gene transfer as a tool for studying transcription regulation of xenobiotic metabolizing enzymes
|
Bonamassa, Barbara |
|
2010 |
154-155 |
13 |
p. 1250-1256 7 p. |
artikel |
43 |
Nuclear receptor coregulators as a new paradigm for therapeutic targeting
|
Hsia, Elaine Y. |
|
2010 |
154-155 |
13 |
p. 1227-1237 11 p. |
artikel |
44 |
Nuclear receptors as drug targets for metabolic disease
|
Schulman, Ira G. |
|
2010 |
154-155 |
13 |
p. 1307-1315 9 p. |
artikel |
45 |
Nuclear receptors in stem cells and their therapeutic potential
|
Sun, GuoQiang |
|
2010 |
154-155 |
13 |
p. 1299-1306 8 p. |
artikel |
46 |
Overcoming drug resistance by regulating nuclear receptors
|
Chen, Taosheng |
|
2010 |
154-155 |
13 |
p. 1257-1264 8 p. |
artikel |
47 |
PEG conjugates in clinical development or use as anticancer agents: An overview
|
Pasut, Gianfranco |
|
2009 |
154-155 |
13 |
p. 1177-1188 12 p. |
artikel |
48 |
Personalized nanomedicine advancements for stem cell tracking
|
Janowski, Miroslaw |
|
2012 |
154-155 |
13 |
p. 1488-1507 20 p. |
artikel |
49 |
Personalized nanomedicine: paving the way to the practical clinical utility of genomics and nanotechnology advancements
|
Vizirianakis, Ioannis S. |
|
2012 |
154-155 |
13 |
p. 1359-1362 4 p. |
artikel |
50 |
Pharmaceutical applications of embryonic stem cells
|
Pouton, Colin W. |
|
2005 |
154-155 |
13 |
p. 1918-1934 17 p. |
artikel |
51 |
Polymeric carriers: Preclinical safety and the regulatory implications for design and development of polymer therapeutics
|
Gaspar, Rogério |
|
2009 |
154-155 |
13 |
p. 1220-1231 12 p. |
artikel |
52 |
Polymer therapeutics: Clinical applications and challenges for development
|
Vicent, María J. |
|
2009 |
154-155 |
13 |
p. 1117-1120 4 p. |
artikel |
53 |
ProLindac™ (AP5346): A review of the development of an HPMA DACH platinum Polymer Therapeutic
|
Nowotnik, David P |
|
2009 |
154-155 |
13 |
p. 1214-1219 6 p. |
artikel |
54 |
Protein–excipient interactions: Mechanisms and biophysical characterization applied to protein formulation development
|
Kamerzell, Tim J. |
|
2011 |
154-155 |
13 |
p. 1118-1159 42 p. |
artikel |
55 |
Protein stabilization by cyclodextrins in the liquid and dried state
|
Serno, Tim |
|
2011 |
154-155 |
13 |
p. 1086-1106 21 p. |
artikel |
56 |
Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR
|
Tolson, Antonia H. |
|
2010 |
154-155 |
13 |
p. 1238-1249 12 p. |
artikel |
57 |
Reprogrammed cell delivery for personalized medicine
|
Wieland, Markus |
|
2012 |
154-155 |
13 |
p. 1477-1487 11 p. |
artikel |
58 |
Retinoid pathway and cancer therapeutics
|
Bushue, Nathan |
|
2010 |
154-155 |
13 |
p. 1285-1298 14 p. |
artikel |
59 |
RNAi-based nanomedicines for targeted personalized therapy
|
Daka, Ala |
|
2012 |
154-155 |
13 |
p. 1508-1521 14 p. |
artikel |
60 |
Selectively targeting estrogen receptors for cancer treatment
|
Shanle, Erin K. |
|
2010 |
154-155 |
13 |
p. 1265-1276 12 p. |
artikel |
61 |
Spatiotemporal control over growth factor signaling for therapeutic neovascularization
|
Cao, Lan |
|
2007 |
154-155 |
13 |
p. 1340-1350 11 p. |
artikel |
62 |
Structural and functional insights into nuclear receptor signaling
|
Jin, Lihua |
|
2010 |
154-155 |
13 |
p. 1218-1226 9 p. |
artikel |
63 |
The UK Stem Cell Bank: Its role as a public research resource centre providing access to well-characterised seed stocks of human stem cell lines
|
Healy, Lyn |
|
2005 |
154-155 |
13 |
p. 1981-1988 8 p. |
artikel |
64 |
Three-dimensional microenvironments modulate fibroblast signaling responses
|
Green, J. Angelo |
|
2007 |
154-155 |
13 |
p. 1293-1298 6 p. |
artikel |
65 |
Transplanting stem cells: Potential targets for immune attack. Modulating the immune response against embryonic stem cell transplantation
|
Boyd, Ashleigh S. |
|
2005 |
154-155 |
13 |
p. 1944-1969 26 p. |
artikel |
66 |
Tumor-targeting multi-functional nanoparticles for theragnosis: New paradigm for cancer therapy
|
Ryu, Ju Hee |
|
2012 |
154-155 |
13 |
p. 1447-1458 12 p. |
artikel |
67 |
Using drug-excipient interactions for siRNA delivery
|
Bruno, Katharina |
|
2011 |
154-155 |
13 |
p. 1210-1226 17 p. |
artikel |
68 |
Viscosity of concentrated therapeutic protein compositions
|
Jezek, Jan |
|
2011 |
154-155 |
13 |
p. 1107-1117 11 p. |
artikel |
69 |
XMT-1001, a novel polymeric camptothecin pro-drug in clinical development for patients with advanced cancer
|
Yurkovetskiy, Alexander V. |
|
2009 |
154-155 |
13 |
p. 1193-1202 10 p. |
artikel |